
News|Articles|September 5, 2013
Waters Corporation Announces CEO Transition Plan
Author(s)Pharmaceutical Technology Editors
CEO of Waters Corporation will retire within in the next two years.
Advertisement
The company’s board of directors has appointed a succession planning committee that will guide the process of selecting a successor and plans to hire an executive search firm to assist in a search, which will consider both internal and external candidates.
Berthiaume, who is 64, was appointed president and CEO of Waters Corporation in 1994 when the business was separated from Millipore, and assumed the additional role of chairman in 1996.
Source:
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Shilpa CDMO to Launch as Dedicated Complex Small-Molecule Contract Development and Manufacturing Brand at CPHI Milan
2
European Regulators Prepare the Pharma Industry for Future Changes as Legislation is Formalized
3
Technology Transfer: Success Drivers and Obstacles Explained
4
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
5




